FindTrial
Sign In

Comparison of ropivacaine and bupivacaine for spinal anaesthesia.

Comparison of 0.75% hyperbaric ropivacaine versus 0.5% hyperbaric bupivacaine in spinal anaesthesia for elective surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046717
Enrollment
50
Registered
2022-10-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: 0.5 % hyperbaric Bupivacaine: Patients will be divided into two groups. Group 1 – 3ml hyperbaric 0.75% ropivacaine Group 2- 3ml hyperbaric 0.5% bupivacaine Patients will be randomly div

Sponsors

Bhabha Atomic Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 18-60 years, ASA grade I-II undergoing elective infra-umbilical surgeries, less than 2hours, under spinal anaesthesia.

Exclusion criteria

Exclusion criteria: Patient refusal Pregnancy Allergy to local anesthetic drugs Any other contra indications to spinal anaesthesia

Design outcomes

Primary

MeasureTime frame
To study duration of action of hyperbaric ropivacaine and hyperbaric bupivacaine.Timepoint: 24hours—

Secondary

MeasureTime frame
To study 1.Time taken to achieve maximum sensory blockade. 2.Time taken to achieve maximum motor blockade. 3.Intra-operative hemodynamics. 4.Time taken for 5 segment regression of sensory block. 5.Time taken for regression of motor blockade to modified Bromage 1. 6.Side effects if any Timepoint: 24hours—

Countries

India

Contacts

Public ContactDr Pragati Volvoikar

Bhabha Atomic Research Centre

shrivic@barc.gov.in9521354101

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026